MedPath

Justin Fraser

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

5

Active:0
Completed:3

Trial Phases

2 Phases

Phase 1:3
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

Phase 1
3 (75.0%)
Not Applicable
1 (25.0%)

Brain, Blood and Clot or Tissue Registry and Collaboration

Recruiting
Conditions
Cerebrovascular Disorders
Acute Ischemic Stroke
First Posted Date
2017-05-15
Last Posted Date
2025-02-21
Lead Sponsor
Justin Fraser
Target Recruit Count
1000
Registration Number
NCT03153683
Locations
🇺🇸

University of Kentucky Deparment of Neurosurgery, UK Chandler Hospital, Lexington, Kentucky, United States

Magnesium And Verapamil After Recanalization in Ischemia of the Cerebrum: a Clinical and Translational Study.

Phase 1
Completed
Conditions
Ischemic Stroke
Interventions
First Posted Date
2016-09-23
Last Posted Date
2020-06-24
Lead Sponsor
Justin Fraser
Target Recruit Count
10
Registration Number
NCT02912663
Locations
🇺🇸

University of Kentucky Medical Center, Lexington, Kentucky, United States

Superselective Citicoline and Verapamil for Ischemic Neuroprotection and Greater Effective Response

Phase 1
Withdrawn
Conditions
Ischemic Stroke
Interventions
First Posted Date
2016-07-06
Last Posted Date
2016-09-23
Lead Sponsor
Justin Fraser
Registration Number
NCT02823106
Locations
🇺🇸

University of Kentucky Medical Center, Lexington, Kentucky, United States

Stroke and Traumatic Acute Brain Injury Line Indicator System for Emergent Recognition (STABILISER-I)

Not Applicable
Completed
Conditions
Ischemic Stroke
Hemorrhagic Stroke
Traumatic Brain Injury
First Posted Date
2015-08-04
Last Posted Date
2017-02-23
Lead Sponsor
Justin Fraser
Target Recruit Count
48
Registration Number
NCT02514902
Locations
🇺🇸

University of Kentucky Deparment of Neurosurgery, UK Chandler Hospital, Lexington, Kentucky, United States

Superselective Administration of VErapamil During Recanalization in Acute Ischemic Stroke

Phase 1
Completed
Conditions
Ischemic Stroke
Interventions
First Posted Date
2014-09-10
Last Posted Date
2017-01-23
Lead Sponsor
Justin Fraser
Target Recruit Count
11
Registration Number
NCT02235558
Locations
🇺🇸

University of Kentucky Deparment of Neurosurgery, UK Chandler Hospital, Lexington, Kentucky, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.